These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 17711462)

  • 1. Are psychiatric adverse events of antiepileptic drugs a unique entity? A study on topiramate and levetiracetam.
    Mula M; Trimble MR; Sander JW
    Epilepsia; 2007 Dec; 48(12):2322-6. PubMed ID: 17711462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topiramate and psychiatric adverse events in patients with epilepsy.
    Mula M; Trimble MR; Lhatoo SD; Sander JW
    Epilepsia; 2003 May; 44(5):659-63. PubMed ID: 12752464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effect of Antiepileptic Drugs on Cognition: Patient Perceived Cognitive Problems of Topiramate versus Levetiracetam in Clinical Practice.
    Bootsma HP; Aldenkamp AP; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
    Epilepsia; 2006; 47 Suppl 2():24-7. PubMed ID: 17105455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
    Stephen LJ; Wishart A; Brodie MJ
    Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of new antiepileptic drugs on circulatory markers for vascular risk in patients with newly diagnosed epilepsy.
    Kim DW; Lee SY; Shon YM; Kim JH
    Epilepsia; 2013 Oct; 54(10):e146-9. PubMed ID: 23980720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
    Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain tumor location influences the onset of acute psychiatric adverse events of levetiracetam therapy: an observational study.
    Belcastro V; Pisani LR; Bellocchi S; Casiraghi P; Gorgone G; Mula M; Pisani F
    J Neurol; 2017 May; 264(5):921-927. PubMed ID: 28315958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative cognitive effects of levetiracetam and topiramate in intractable epilepsy.
    Huang CW; Pai MC; Tsai JJ
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):548-53. PubMed ID: 18950374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
    Roberts GM; Majoie HJ; Leenen LA; Bootsma HP; Kessels AG; Aldenkamp AP; Leonard BE
    Epilepsy Behav; 2005 May; 6(3):366-72. PubMed ID: 15820345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis.
    Luszczki JJ; Andres MM; Czuczwar P; Cioczek-Czuczwar A; Ratnaraj N; Patsalos PN; Czuczwar SJ
    Epilepsia; 2006 Jan; 47(1):10-20. PubMed ID: 16417526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A past psychiatric history may be a risk factor for topiramate-related psychiatric and cognitive adverse events.
    Kanner AM; Wuu J; Faught E; Tatum WO; Fix A; French JA;
    Epilepsy Behav; 2003 Oct; 4(5):548-52. PubMed ID: 14527497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Efficacy and tolerability of topiramate, lamotrigine, and levetiracetam in children with refractory epilepsy].
    Kato T; Nakata M; Ide M; Saito K; Yoshida T; Awaya T; Heike T
    No To Hattatsu; 2015 Sep; 47(5):354-9. PubMed ID: 26502652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate.
    Gomer B; Wagner K; Frings L; Saar J; Carius A; Härle M; Steinhoff BJ; Schulze-Bonhage A
    Epilepsy Behav; 2007 May; 10(3):486-94. PubMed ID: 17409025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eslicarbazepine acetate as a replacement for levetiracetam in people with epilepsy developing behavioral adverse events.
    Jalihal V; Shankar R; Henley W; Parrett M; Tittensor P; McLean BN; Ahmed A; Sander JW
    Epilepsy Behav; 2018 Mar; 80():365-369. PubMed ID: 29415871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of side effects on long-term retention in three new antiepileptic drugs.
    Bootsma HP; Ricker L; Hekster YA; Hulsman J; Lambrechts D; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2009 Jun; 18(5):327-31. PubMed ID: 19110447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric symptoms after therapy with new antiepileptic drugs: psychopathological and seizure related variables.
    Trimble MR; Rüsch N; Betts T; Crawford PM
    Seizure; 2000 Jun; 9(4):249-54. PubMed ID: 10880283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy.
    Otoul C; De Smedt H; Stockis A
    Epilepsia; 2007 Nov; 48(11):2111-5. PubMed ID: 17651416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychiatric and behavioral side effects of antiepileptic drugs in adults with epilepsy.
    Chen B; Choi H; Hirsch LJ; Katz A; Legge A; Buchsbaum R; Detyniecki K
    Epilepsy Behav; 2017 Nov; 76():24-31. PubMed ID: 28931473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.